APSR2026-211

 
Late-Breaking
Submitted
Poster Presentation
 
AP14-030
P49
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1213446-46904-UITM PPSC APSR SYAHRIN_439470.pdf
Format: PDF Only
08. Lung Cancer
5

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Syahrinnaquiah Samsuddin * University Technology MARA, Sungai Buloh Department of Medicine Selangor Malaysia
Am Basheeri Alias - University Technology MARA, Sungai Buloh Department of Medicine Selangor Malaysia
Aisya Natasya Musa - University Technology MARA, Sungai Buloh Department of Medicine Selangor Malaysia
Yen Shen Wong - University Technology MARA, Sungai Buloh Department of Medicine Selangor Malaysia
Nor Salmah Bakar - University Technology MARA, Sungai Buloh Department of Pathology Selangor Malaysia
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Syahrinnaquiah
Samsuddin
syahrin.samsuddin@gmail.com
+60193884887
31-40
Malaysia
Case Report
A Rare Case of Pulmonary Pleomorphic Sarcomatoid Carcinoma
Maximum 25 words
Abstract Content
 
 
 
 
Pulmonary sarcomatoid carcinoma (PSC) is a rare and aggressive form of non-small cell lung cancer, accounting for less than 1% of lung malignancies, and is strongly associated with smoking. The diagnosis requires careful histopathological and immunohistochemical evaluation. Treatment itself can be challenging, as it is shown to be less effective with chemotherapy and radiotherapy. We report a rare case of pulmonary sarcomatoid carcinoma.
A 63-year-old active smoker presented with two months of cough and hemoptysis, associated with constitutional symptoms. There was no family history of malignancy. Tuberculosis screening was negative. CT thorax demonstrated a right upper lobe mass with extensive emphysema. Persistent hemoptysis required bronchial artery embolization. PET-CT demonstrated an FDG-avid irregular right upper lobe mass (SUVmax 12.5) with spiculation extending to the pleura. FDG-avid mediastinal and right hilar lymph nodes were noted (SUVmax 10.5), without distant metastases. Histology showed extensive necrosis with viable tumor cells displaying spindle and rhabdoid morphology, marked nuclear pleomorphism, and degenerative changes. Immunohistochemistry demonstrated diffuse positivity for CKAE, CK7, and vimentin, while TTF-1 and p40 were negative, consistent with pulmonary sarcomatoid carcinoma, pleomorphic subtype. Staging was T2N2bM0 (stage IIIb). The patient was then referred to oncology for further management.
PSC is characterized by poorly differentiated carcinoma with sarcomatoid features and typically presents with a large, metabolically active peripheral mass. The pleomorphic subtype, as seen here, is the most common. Molecular study and immunohistochemistry can assist in terms of treatment options, as this type of malignancy is usually refractory to conventional platinum-based chemotherapy and radiotherapy. Surgery is the mainstay of treatment, but it is highly aggressive with a median overall survival ranging from 3 to 8.5 months.
 
 
No
No
 
JPG or JPEG or PNG format ONLY
lung, non-small cell carcinoma, sarcomatoid
maximum 3 keywords and no abbreviations, separated by commas
Nothing to disclose.
274